The Huntingtin mutation can either activate or decrease p53 activity, and an inhibition of p53 in the “mitochondrial dysfunction in neurodegenerative diseases” pathway can lead to p21 under-expression, leading to the inhibition of neuronal cell survival [96]. Here, CDKN1A is linked to neurodegenerative disease.